StonvexLoading…
StonvexStonvexStonvexCore line items from CTSH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $5.41B | $21.11B | $15.78B | $10.36B |
Operating Income | $843.00M | $3.39B | $2.54B | $1.67B |
Net Income | $662.00M | $2.23B | $1.58B | $645.00M |
EPS (Diluted) | $1.39 | $4.56 | $3.22 | $2.65 |
Total Assets | $20.50B | $20.69B | $20.13B | $20.16B |
Total Liabilities | $5.43B | $5.68B | $5.24B | $4.88B |
Cash & Equivalents | $1.50B | $1.90B | $2.34B | $1.80B |
Free Cash Flow OCF − CapEx | $198.00M | $2.60B | $1.81B | $654.00M |
Shares Outstanding | 474.00M | 479.00M | 483.00M | 489.00M |